Lack of Equipoise in the PDA-TOLERATE Trial: A Comparison of Eligible Infants Enrolled in the Trial and Those Treated Outside the Trial

PDA-TOLERATE (PDA: TO LEave it alone or Respond And Treat Early) Trial Investigators

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

The PDA: TO LEave it alone or Respond And Treat Early trial compared the effects of 2 strategies for treatment of patent ductus arteriosus (PDA) in infants <280/7 weeks of gestation; however 137 potentially eligible infants were not recruited and received treatment of their PDA outside the PDA-TOLERATE trial due to “lack-of-physician-equipoise” (LPE). Despite being less mature and needing more respiratory support, infants with LPE had lower rates of mortality than enrolled infants. Infants with LPE treated before day 6 had lower rates of late respiratory morbidity than infants with LPE treated ≥day 6. Trial registration: ClinicalTrials.gov: NCT01958320.

Original languageEnglish (US)
Pages (from-to)222-226.e2
JournalJournal of Pediatrics
Volume213
DOIs
StatePublished - Oct 2019

Keywords

  • bronchopulmonary dysplasia
  • patent ductus arteriosus
  • premature birth

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Lack of Equipoise in the PDA-TOLERATE Trial: A Comparison of Eligible Infants Enrolled in the Trial and Those Treated Outside the Trial'. Together they form a unique fingerprint.

Cite this